Literature DB >> 12495283

Hyperbaric oxygen therapy for calcific uremic arteriolopathy: a case series.

Carlo Basile1, Alessio Montanaro, Maria Masi, Gina Pati, Pasquale De Maio, Antonio Gismondi.   

Abstract

Calcific uremic arteriolopathy (CUA), also referred to as calciphylaxis, is a syndrome of small vessel calcification of unknown etiology causing painful violaceous skin lesions that progress to non-healing ulcers and gangrene. It is observed mainly in patients with end-stage renal disease, is associated with high morbidity and mortality and has no standard treatment at the present time. Although parathyroidectomy (PTX) has been advocated in some cases, other studies have not found this effective. Hyperbaric oxygen therapy (HOT) consists of breathing 100% O2 at higher than ambient pressure, with the patient inside a sealed chamber. HOT has been used with some success in the treatment of selected problem wounds (those that fail to respond to established medical and surgical management). They are often severely hypoxic; restoration of tissue PO2 to normal or above-normal enhances fibroblast proliferation and collagen production as well as angiogenesis. The present is the largest retrospective case series of CUA treated by means of HOT reported so far and comprises 11 chronic uremic patients on dialysis (9 hemo- and 2 peritoneal dialysis, 6 females and 5 males, mean age 56 +/- 7 SD years, time on dialysis 163 +/- 84 SD months). Four patients had biopsy-proven CUA; 3 had diabetic nephropathy as a cause of uremia; 2 were obese and 3 had a consistent increase of serum calcium x phosphorus product; 3 patients had severe secondary hyperparathyroidism (II(nd) HPTH) and two had been submitted to subtotal PTX some years before CUA; two others had already had the limb amputated. Lesions were in the legs, except for one in a hand, and were prevalently ulcers and necrosis. The number of sessions in each HOT cycle ranged from a minimum of 20 to a maximum of 108 (mean 40.6 +/- 29.0). The results of two therapies cannot be evaluated (one was interrupted by the patient after 10 sessions, and one ended with the death of the patient due to ventricular arrhythmia after eight sessions). Eight of the nine remaining had excellent results with healing of the skin ulcers, but the ninth got worse, making it advisable to amputate the foot. In conclusion, CUA appears to result from a multitude of predisposing and/or sensitizing events that are commonly present in the uremic milieu. The specific factors that induce this disorder in an individual patient are not known. The present retrospective study supports a role of HOT in many cases of CUA, especially considering that, in the absence of severe II(nd) HPTH, there are very few therapeutic options.

Entities:  

Mesh:

Year:  2002        PMID: 12495283

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  25 in total

1.  Calciphylaxis: a review.

Authors:  Avani Bhambri; James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2008-07

2.  A case report: radiological findings in an unusual case of calciphylaxis 16 years after renal transplantation.

Authors:  Sarahn Smith; Akimichi Inaba; Joseph Murphy; Gary Campbell; Andoni P Toms
Journal:  Skeletal Radiol       Date:  2013-06-11       Impact factor: 2.199

3.  Painful skin ulcers in a hemodialysis patient.

Authors:  Stuart M Sprague
Journal:  Clin J Am Soc Nephrol       Date:  2013-11-07       Impact factor: 8.237

Review 4.  Calciphylaxis: risk factors, diagnosis, and treatment.

Authors:  Sagar U Nigwekar; Daniela Kroshinsky; Rosalynn M Nazarian; Jeremy Goverman; Rajeev Malhotra; Vicki Ann Jackson; Mihir M Kamdar; David J R Steele; Ravi I Thadhani
Journal:  Am J Kidney Dis       Date:  2015-05-07       Impact factor: 8.860

Review 5.  [Cutaneous calciphylaxis].

Authors:  U Wollina
Journal:  Hautarzt       Date:  2010-12       Impact factor: 0.751

6.  Patient Outcomes and Factors Associated with Healing in Calciphylaxis Patients Undergoing Adjunctive Hyperbaric Oxygen Therapy.

Authors:  Norman McCulloch; Susan M Wojcik; Marvin Heyboer
Journal:  J Am Coll Clin Wound Spec       Date:  2016-08-30

7.  Surviving calciphylaxis.

Authors:  Paul Lee; Jacob Sevastos; Lesley V Campbell
Journal:  J Bone Miner Metab       Date:  2008-12-05       Impact factor: 2.626

Review 8.  Calcific uremic arteriolopathy: pathophysiology, reactive oxygen species and therapeutic approaches.

Authors:  Kurt M Sowers; Melvin R Hayden
Journal:  Oxid Med Cell Longev       Date:  2010 Mar-Apr       Impact factor: 6.543

Review 9.  Is there a role for hyperbaric oxygen therapy in the treatment of refractory wounds of rare etiology?

Authors:  Pasquale Longobardi; Klarida Hoxha; Michael H Bennett
Journal:  Diving Hyperb Med       Date:  2019-09-30       Impact factor: 0.887

10.  Non-uraemic calciphylaxis (NUC) postliver transplantation.

Authors:  Simona Frunza-Stefan; Silpa Poola-Kella; Kristi Silver
Journal:  BMJ Case Rep       Date:  2018-10-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.